EGF (Epidermal growth factor)

News alerts, weekly reports and conference planners

Entrez ID:

EGF rs444903	Colorectal Cancer	EGF rs444903	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
EGF overexpression	Breast Cancer	EGF overexpression	Breast Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
EGF expression	Tongue Carcinoma	EGF expression	Tongue Carcinoma	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D

Associations(3)